Evidence mapPaperPMID 39375863Full record

ArticleDiabetes, obesity & metabolism2025

Somatic and mental symptoms associated with dysglycaemia, diabetes-related complications and mental conditions in people with diabetes: Assessments in daily life using continuous glucose monitoring and ecological momentary assessment.

Norbert Hermanns, Dominic Ehrmann, Bernhard Kulzer, Laura Klinker, Thomas Haak, Andreas Schmitt

Abstract read
In one paragraph

Article in Diabetes, obesity & metabolism, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Norbert HermannsResearch Institute of the Diabetes-Academy Mergentheim (FIDAM), Bad Mergentheim, Germany.ORCID 0000-0002-2903-2677
Dominic EhrmannResearch Institute of the Diabetes-Academy Mergentheim (FIDAM), Bad Mergentheim, Germany.ORCID 0000-0002-5794-5596
Bernhard KulzerResearch Institute of the Diabetes-Academy Mergentheim (FIDAM), Bad Mergentheim, Germany.ORCID 0000-0001-9120-4479
Laura KlinkerResearch Institute of the Diabetes-Academy Mergentheim (FIDAM), Bad Mergentheim, Germany.ORCID 0000-0002-9484-3257
Thomas HaakDiabetes Center Mergentheim (DZM), Diabetes Clinic, Bad Mergentheim, Germany.
Andreas SchmittResearch Institute of the Diabetes-Academy Mergentheim (FIDAM), Bad Mergentheim, Germany.ORCID 0000-0002-5913-1457

Funding

Abbott Diabetes CareGerman Center for Diabetes Research (DZD) FKZ 82DZD01102German Center for Diabetes Research (DZD) FKZ 82DZD11E03
6 · The paper itself

Abstract

aimTo analyse the potential drivers (glucose level, complications, diabetes type, gender, age and mental health) of diabetes symptoms using continuous glucose monitoring (CGM) and ecological momentary assessment. MATERIALS AND

methodsParticipants used a smartphone application to rate 25 diabetes symptoms in their daily lives over 8 days. These symptoms were grouped into four blocks so that each symptom was rated six times on 2 days (noon, afternoon and evening). The symptom ratings were associated with the glucose levels for the previous 2 hours, measured with CGM. Linear mixed-effects models were used, allowing for nested random effects and the conduct of N = 1 analysis of individual associations.

resultsIn total, 192 individuals with type 1 diabetes and 179 with type 2 diabetes completed 6380 app check-ins. Four symptoms showed a significant negative association with glucose values, indicating higher ratings at lower glucose (speech difficulties, P = .003; coordination problems, P = .00005; confusion, P = .049; and food cravings, P = .0003). Four symptoms showed a significant positive association with glucose values, indicating higher scores at higher glucose (thirst, P = .0001; urination, P = .0003; taste disturbances, P = .021; and itching, P = .0120). There were also significant positive associations between microangiopathy and eight symptoms. Elevated depression and diabetes distress were associated with higher symptom scores. N = 1 analysis showed highly idiosyncratic associations between symptom reports and glucose levels.

conclusionsThe N = 1 analysis facilitated the creation of personalized symptom profiles related to glucose levels with consideration of factors such as complications, gender, body mass index, depression and diabetes distress. This approach can enhance precision monitoring for diabetes symptoms in precision medicine.

Indexed as

Blood GlucoseBlood Glucose Self-MonitoringDiabetes Mellitus, Type 1Diabetes Mellitus, Type 2Ecological Momentary AssessmentAdultAgedContinuous Glucose MonitoringDiabetes ComplicationsFemaleHumansHyperglycemiaMaleMental DisordersMiddle AgedMobile ApplicationsBlood Glucosecontinuous glucose monitoringhypoglycaemiapatient‐reported outcomestype 1 diabetestype 2 diabetes

Identifiers

PMID39375863
PMCPMC11618240

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.